Skip to main content
. 2020 Apr 3;10:435. doi: 10.3389/fonc.2020.00435

Figure 1.

Figure 1

Drugs included in the screen based on their selectivity toward AML cells. Survival of AML cells (OCI-AML2 or MOLM-13) or healthy PBMCs following 24 h treatment with (A) rotenone, (B) CCCP, (C) vinorelbine, (D) 2-deoxy-D-glucose, (E) 3-bromopyruvate, (F) lonidamine. The average of at least three independent replicates ± SEM is shown. Significance of difference in survival (AML cells vs. PBMCs) was assessed via Student's t-test. ***p < 0.001; **p < 0.01; *p < 0.05; ns: p > 0.05.